Categories Earnings, Technology

Zebra Technologies (ZBRA): Q4 2019 Earnings Snapshot

— Zebra Technologies Corporation (NASDAQ: ZBRA) reported adjusted earnings of $3.56 per share for the fourth quarter of 2019, vs. $3.65 per share expected.

— Net income increased to $169 million or $3.10 per share from $115 million or $2.11 per share in the fourth quarter of 2018

— At $1.19 billion, fourth-quarter net sales were up 4.8% year-over-year, vs. $1.2 billion expected

— Adjusted EBITDA increased 6.3% annually to $255 million during the three-month period

— Expects first-quarter 2020 net sales to increase 4%-7% year-over-year, which includes one percentage point additive impact from acquisitions

— First-quarter adjusted EBITDA margin is expected to be 20%; adjusted earnings are expected to be in the range of $2.90 per share to $3.10 per share

— Expects full-year 2020 net sales to rise 4%-6% from last year, which includes about 30 basis point positive impact from acquisitions

— Full-year adjusted EBITDA margin is expected to be slightly above 22%; looking to generate free cash flow of at least $700 million in 2020

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top